Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02264249 · ClinicalTrials.gov registry record
Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation
A clinical trial of Colonoscopy and Esophagogastroduodenoscopy, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 449
- Enrollment target
- 1
- Study location
NCT02264249: Completed study of Colonoscopy and Esophagogastroduodenoscopy, sponsored by The Cleveland Clinic.
NCT02264249 is a study of Colonoscopy and Esophagogastroduodenoscopy that has completed, run by The Cleveland Clinic. The registered enrollment target is 449 participants, roughly in line with the 479-participant average among 20 other Colonoscopy trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02264249, a study of Colonoscopy and Esophagogastroduodenoscopy, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 449 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine residual gastric volume and residual gastric pH in patients undergoing combined EGD and colonoscopy comparing the standard single dose prep with the split dose bowel preparation and same day bowel preparations.
Primary Outcome
The residual gastric volume for the patients undergoing a combined esophagogastroduodenoscopy and colonoscopy will be measured and compared among the groups taking different bowel preparations.
Conditions Studied
Interventions
- OTHER Esophagogastroduodenoscopy and colonoscopy split dose prep
- OTHER Esophagogastroduodenoscopy and colonoscopy Evening before colonoscopy prep
- OTHER Esophagogastroduodenoscopy and colonoscopy Same day prep colonoscopy preparation
Study Locations (1)
Florida
- Cleveland Clinic Florida - Weston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 449 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-02 |
What the finished NCT02264249 record still lists
NCT02264249 is an observational study that tracks outcomes without assigning an intervention. The registered 449 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 479-participant average among 20 other Colonoscopy trials with a reported enrollment target.
The record links to 2 conditions, with Colonoscopy appearing as the primary indexed condition, and to 3 interventions - of which Esophagogastroduodenoscopy and colonoscopy split dose prep is the first listed.
NCT02264249 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02264249 about?
NCT02264249 is a clinical study titled "Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation". The purpose of this study is to determine residual gastric volume and residual gastric pH in patients undergoing combined EGD and colonoscopy comparing the standard single dose prep with the split dose bowel preparation and same day bowel preparations.
What is the current status of trial NCT02264249?
This trial is currently completed. The enrollment target is 449 participants. The study started on 2014-09. Estimated completion is 2016-02.
What conditions does trial NCT02264249 study?
This clinical trial studies the following conditions: Colonoscopy, Esophagogastroduodenoscopy.
What interventions are being tested in trial NCT02264249?
The interventions under investigation include: Esophagogastroduodenoscopy and colonoscopy split dose prep (OTHER), Esophagogastroduodenoscopy and colonoscopy Evening before colonoscopy prep (OTHER), Esophagogastroduodenoscopy and colonoscopy Same day prep colonoscopy preparation (OTHER).
Who is sponsoring clinical trial NCT02264249?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02264249 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02264249's enrollment target sits among peer trials
449 8th of 20 higher than 13 of 20 other Colonoscopy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colonoscopy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures?
RECRUITING · Phase 4
-
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
RECRUITING
-
Endoscopic Resection of Large Colorectal Polyps: An Observational Cohort Study
RECRUITING
-
Impact of Artificial Intelligence on Trainee Polyp Miss Rates
RECRUITING · NA
-
Cold Snare Endoscopic Mucosal Resection Trial
ACTIVE NOT RECRUITING · NA
-
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia